ATE531387T1 - Nahtlinien-verabreichungstechnik mit botulinustoxinen - Google Patents
Nahtlinien-verabreichungstechnik mit botulinustoxinenInfo
- Publication number
- ATE531387T1 ATE531387T1 AT09727789T AT09727789T ATE531387T1 AT E531387 T1 ATE531387 T1 AT E531387T1 AT 09727789 T AT09727789 T AT 09727789T AT 09727789 T AT09727789 T AT 09727789T AT E531387 T1 ATE531387 T1 AT E531387T1
- Authority
- AT
- Austria
- Prior art keywords
- suture line
- administration technique
- line administration
- botulinus
- toxins
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24069—Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/062,372 US8617571B2 (en) | 2008-04-03 | 2008-04-03 | Suture line administration technique using botulinum toxin |
PCT/US2009/038950 WO2009124046A1 (en) | 2008-04-03 | 2009-03-31 | Suture line administration technique using botulinum toxins |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE531387T1 true ATE531387T1 (de) | 2011-11-15 |
Family
ID=41016982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT09727789T ATE531387T1 (de) | 2008-04-03 | 2009-03-31 | Nahtlinien-verabreichungstechnik mit botulinustoxinen |
Country Status (12)
Country | Link |
---|---|
US (7) | US8617571B2 (de) |
EP (2) | EP2392344B1 (de) |
CN (1) | CN102056620A (de) |
AT (1) | ATE531387T1 (de) |
AU (1) | AU2009231786B2 (de) |
BR (1) | BRPI0910993A2 (de) |
CA (1) | CA2720112C (de) |
DK (1) | DK2282766T3 (de) |
ES (2) | ES2372678T3 (de) |
MX (1) | MX2010010885A (de) |
NZ (3) | NZ600858A (de) |
WO (1) | WO2009124046A1 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7780967B2 (en) * | 2000-02-08 | 2010-08-24 | Allergan, Inc. | Reduced toxicity Clostridial toxin pharmaceutical compositions |
US6440312B1 (en) | 2000-05-02 | 2002-08-27 | Kai Technologies, Inc. | Extracting oil and water from drill cuttings using RF energy |
US20050191321A1 (en) * | 2004-02-26 | 2005-09-01 | Allergan, Inc. | Methods for treating headache |
US20100266638A1 (en) | 2004-02-26 | 2010-10-21 | Allergan, Inc. | Headache treatment method |
US9078892B2 (en) * | 2004-02-26 | 2015-07-14 | Allergan, Inc. | Methods for treating pain and for treating a medication overuse disorder |
US9211248B2 (en) | 2004-03-03 | 2015-12-15 | Revance Therapeutics, Inc. | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
US7655244B2 (en) | 2005-02-01 | 2010-02-02 | Allergan, Inc. | Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions |
US7749515B2 (en) | 2005-02-01 | 2010-07-06 | Allergan, Inc. | Targeted delivery of botulinum toxin to the sphenopalatine ganglion |
US8617571B2 (en) * | 2008-04-03 | 2013-12-31 | Allergan, Inc. | Suture line administration technique using botulinum toxin |
EP2512507A4 (de) * | 2009-12-15 | 2013-04-17 | Ira Sanders | Behandlung von nasen- und brustleiden |
US9764009B2 (en) * | 2011-06-13 | 2017-09-19 | Allergan, Inc. | Treatment of psychological trauma |
US9480731B2 (en) | 2013-12-12 | 2016-11-01 | Medy-Tox, Inc. | Long lasting effect of new botulinum toxin formulations |
CN105251041A (zh) * | 2015-10-28 | 2016-01-20 | 钊桂英 | 一种纯天然胶原蛋白医用缝合线及制备方法 |
KR20240023684A (ko) | 2016-09-13 | 2024-02-22 | 알레간 인코포레이티드 | 안정화된 비단백질 클로스트리듐 독소 조성물 |
US10932711B2 (en) | 2017-02-27 | 2021-03-02 | Payman Sadeghi | Method and system for neurohydrodissection |
EP3694587A4 (de) * | 2017-10-12 | 2021-08-11 | Leslie, Tufts | Verfahren und vorrichtung zur injektion eines neurotoxins in einen lokalisierten bereich |
AU2019299676A1 (en) | 2018-07-05 | 2021-01-28 | Allergan Pharmaceuticals International Limited | Combination therapy with CGRP antagonists and Clostridial derivatives |
WO2021005494A1 (en) | 2019-07-05 | 2021-01-14 | Allergan Pharmaceuticals International Limited | Cgrp antagonists and clostridial derivatives for the treatment of neuropsychiatric and neurological disorders |
WO2021005497A1 (en) | 2019-07-05 | 2021-01-14 | Allergan Pharmaceuticals International Limited | Cgrp antagonists and clostridial derivatives for the treatment of cortical spreading depression associated disorders |
US20210130445A1 (en) | 2019-07-05 | 2021-05-06 | Allergan Pharmaceuticals International Limited | CGRP Antagonists and Botulinum Toxins for the Treatment of Inflammatory and Neurologic Disorders |
WO2021247890A1 (en) * | 2020-06-03 | 2021-12-09 | Miotox, Llc | Zonal and targeted methods and uses for treating a migraine disorder |
WO2023091469A1 (en) * | 2021-11-17 | 2023-05-25 | The Board Of Trustees Of The Leland Stanford Junior University | Targeting periosteal tissue for delivery of therapeutics |
WO2024112924A2 (en) * | 2022-11-22 | 2024-05-30 | AEON Biopharma, Inc. | Optimization of botulinum toxin treatment of migraine and other headache disorders |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA962933A (en) | 1969-12-05 | 1975-02-18 | Yutaka Hori | Metal foil-plastic laminated film and method of producing the same |
US5437291A (en) | 1993-08-26 | 1995-08-01 | Univ Johns Hopkins | Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction |
US6974578B1 (en) | 1993-12-28 | 2005-12-13 | Allergan, Inc. | Method for treating secretions and glands using botulinum toxin |
US5766605A (en) | 1994-04-15 | 1998-06-16 | Mount Sinai School Of Medicine Of The City University Of New York | Treatment of autonomic nerve dysfunction with botulinum toxin |
US5670484A (en) | 1994-05-09 | 1997-09-23 | Binder; William J. | Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders |
ES2238969T3 (es) * | 1994-05-09 | 2005-09-16 | William J. Binder | Neurotoxinas presinapticas para el tratamiento de cefaleas migrañosas. |
GB9508204D0 (en) | 1995-04-21 | 1995-06-07 | Speywood Lab Ltd | A novel agent able to modify peripheral afferent function |
US6063768A (en) | 1997-09-04 | 2000-05-16 | First; Eric R. | Application of botulinum toxin to the management of neurogenic inflammatory disorders |
CN1324246A (zh) | 1998-10-27 | 2001-11-28 | 梅约医学教育与研究基金会 | 增加伤口愈合的方法 |
US6358917B1 (en) * | 1999-08-24 | 2002-03-19 | Jean D. A. Carruthers | Cosmetic use of botulinum toxin for treatment of downturned mouth |
US6265379B1 (en) | 1999-10-13 | 2001-07-24 | Allergan Sales, Inc. | Method for treating otic disorders |
US6139845A (en) | 1999-12-07 | 2000-10-31 | Allergan Sales, Inc. | Method for treating cancer with a neurotoxin |
US6464986B1 (en) | 2000-04-14 | 2002-10-15 | Allegan Sales, Inc. | Method for treating pain by peripheral administration of a neurotoxin |
US6299893B1 (en) | 2000-04-17 | 2001-10-09 | Marvin Schwartz | Method to reduce hair loss and stimulate hair regrowth |
US6306423B1 (en) | 2000-06-02 | 2001-10-23 | Allergan Sales, Inc. | Neurotoxin implant |
US6423319B1 (en) | 2000-10-04 | 2002-07-23 | Allergan Sales, Inc. | Methods for treating muscle injuries |
US6787517B1 (en) * | 2000-12-29 | 2004-09-07 | Allergan, Inc. | Agent and methods for treating pain |
AU2002355730B2 (en) | 2001-07-27 | 2007-09-13 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Botulinum toxin in the treatment or prevention of acne |
US6623742B2 (en) | 2001-09-17 | 2003-09-23 | Allergan, Inc. | Methods for treating fibromyalgia |
DE10150415A1 (de) | 2001-10-11 | 2003-05-15 | Andres O Ceballos-Baumann | Arzneimittel zur Prophylaxe und Therapie von Depressionen |
US20030224019A1 (en) | 2002-03-01 | 2003-12-04 | O'brien Christopher | Methods of treating nerve entrapment syndromes |
US20040009180A1 (en) | 2002-07-11 | 2004-01-15 | Allergan, Inc. | Transdermal botulinum toxin compositions |
US7393537B2 (en) | 2003-04-25 | 2008-07-01 | Allergan, Inc. | Botulinum toxin for treatment of obsessive compulsive finger biting disorder |
US6838434B2 (en) | 2003-05-02 | 2005-01-04 | Allergan, Inc. | Methods for treating sinus headache |
US8734810B2 (en) | 2003-10-29 | 2014-05-27 | Allergan, Inc. | Botulinum toxin treatments of neurological and neuropsychiatric disorders |
US8617572B2 (en) * | 2003-10-29 | 2013-12-31 | Allergan, Inc. | Botulinum toxin treatments of depression |
US20050191321A1 (en) | 2004-02-26 | 2005-09-01 | Allergan, Inc. | Methods for treating headache |
US20100266638A1 (en) * | 2004-02-26 | 2010-10-21 | Allergan, Inc. | Headache treatment method |
US9078892B2 (en) | 2004-02-26 | 2015-07-14 | Allergan, Inc. | Methods for treating pain and for treating a medication overuse disorder |
US7691381B2 (en) * | 2004-04-15 | 2010-04-06 | Allergan, Inc. | Stabilized biodegradable neurotoxin implants |
US7655244B2 (en) | 2005-02-01 | 2010-02-02 | Allergan, Inc. | Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions |
WO2006082339A1 (fr) | 2005-02-02 | 2006-08-10 | France Telecom | Procede et systeme d'identification par code contextuel |
US7910116B2 (en) | 2005-08-24 | 2011-03-22 | Allergan, Inc. | Use of a botulinum toxin to improve gastric emptying and/or to treat GERD |
US8617571B2 (en) * | 2008-04-03 | 2013-12-31 | Allergan, Inc. | Suture line administration technique using botulinum toxin |
CA2745657C (en) * | 2008-12-04 | 2022-06-21 | Botulinum Toxin Research Associates, Inc. | Extended length botulinum toxin formulation for human or mammalian use |
EP2627350A1 (de) * | 2010-10-14 | 2013-08-21 | Allergan, Inc. | Gezielte abgabe von gezielten exozytosemodulatoren an das ganglion sphenopalatinum zur behandlung von kopfschmerzen |
US10111938B2 (en) * | 2011-03-30 | 2018-10-30 | Allergan, Inc. | Injection paradigm for administration of botulinum toxins |
US9764009B2 (en) * | 2011-06-13 | 2017-09-19 | Allergan, Inc. | Treatment of psychological trauma |
US20130236446A1 (en) * | 2012-03-12 | 2013-09-12 | William J. Binder | Treatment of migraine headache with diffusion of toxin in non-muscle related areas of the mouth |
US20150231068A1 (en) * | 2012-03-12 | 2015-08-20 | Miotox, Llc | Treatment of Migraine Headaches with Presynaptic Neurotoxin |
US9068851B2 (en) | 2013-01-24 | 2015-06-30 | Sap Se | Location and distance based reminders |
AU2019299676A1 (en) * | 2018-07-05 | 2021-01-28 | Allergan Pharmaceuticals International Limited | Combination therapy with CGRP antagonists and Clostridial derivatives |
-
2008
- 2008-04-03 US US12/062,372 patent/US8617571B2/en active Active
-
2009
- 2009-03-31 WO PCT/US2009/038950 patent/WO2009124046A1/en active Application Filing
- 2009-03-31 DK DK09727789.1T patent/DK2282766T3/da active
- 2009-03-31 NZ NZ600858A patent/NZ600858A/xx not_active IP Right Cessation
- 2009-03-31 NZ NZ588648A patent/NZ588648A/xx not_active IP Right Cessation
- 2009-03-31 CN CN2009801208875A patent/CN102056620A/zh active Pending
- 2009-03-31 EP EP11179527A patent/EP2392344B1/de active Active
- 2009-03-31 BR BRPI0910993A patent/BRPI0910993A2/pt not_active IP Right Cessation
- 2009-03-31 EP EP09727789A patent/EP2282766B1/de active Active
- 2009-03-31 ES ES09727789T patent/ES2372678T3/es active Active
- 2009-03-31 CA CA2720112A patent/CA2720112C/en active Active
- 2009-03-31 AU AU2009231786A patent/AU2009231786B2/en active Active
- 2009-03-31 ES ES11179527T patent/ES2398904T3/es active Active
- 2009-03-31 MX MX2010010885A patent/MX2010010885A/es active IP Right Grant
- 2009-03-31 AT AT09727789T patent/ATE531387T1/de active
- 2009-03-31 NZ NZ603717A patent/NZ603717A/en not_active IP Right Cessation
-
2013
- 2013-11-21 US US14/086,760 patent/US9248168B2/en active Active
-
2016
- 2016-02-01 US US15/012,259 patent/US9827297B2/en active Active
-
2017
- 2017-11-27 US US15/822,573 patent/US10220079B2/en active Active
-
2019
- 2019-03-04 US US16/291,383 patent/US10874722B2/en active Active
-
2020
- 2020-12-11 US US17/119,880 patent/US20210121543A1/en not_active Abandoned
-
2022
- 2022-11-23 US US18/058,411 patent/US20230263869A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20090252764A1 (en) | 2009-10-08 |
NZ600858A (en) | 2012-12-21 |
MX2010010885A (es) | 2010-11-04 |
US10220079B2 (en) | 2019-03-05 |
US20190240299A1 (en) | 2019-08-08 |
US9248168B2 (en) | 2016-02-02 |
BRPI0910993A2 (pt) | 2015-12-29 |
ES2372678T3 (es) | 2012-01-25 |
US9827297B2 (en) | 2017-11-28 |
US10874722B2 (en) | 2020-12-29 |
WO2009124046A1 (en) | 2009-10-08 |
US20140079687A1 (en) | 2014-03-20 |
NZ603717A (en) | 2014-02-28 |
US20210121543A1 (en) | 2021-04-29 |
US8617571B2 (en) | 2013-12-31 |
US20180078622A1 (en) | 2018-03-22 |
CA2720112C (en) | 2014-09-23 |
US20230263869A1 (en) | 2023-08-24 |
ES2398904T3 (es) | 2013-03-22 |
EP2392344B1 (de) | 2012-12-19 |
EP2282766B1 (de) | 2011-11-02 |
NZ588648A (en) | 2012-11-30 |
EP2392344A1 (de) | 2011-12-07 |
DK2282766T3 (da) | 2012-01-02 |
EP2282766A1 (de) | 2011-02-16 |
CA2720112A1 (en) | 2009-10-08 |
AU2009231786A1 (en) | 2009-10-08 |
AU2009231786B2 (en) | 2015-06-18 |
US20160151468A1 (en) | 2016-06-02 |
CN102056620A (zh) | 2011-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE531387T1 (de) | Nahtlinien-verabreichungstechnik mit botulinustoxinen | |
TW200503751A (en) | Methods for treating sinus headache | |
MX2010006731A (es) | Uso de un componente neurotoxico de un complejo de toxina de clostridium botulinum para reducir o prevenir efectos secundarios. | |
DE602004017343D1 (de) | Behandlungen mit botulinum toxin von neurologische und neuropsychiatrische krankheiten | |
BRPI0417493A (pt) | terapia com toxina botulìnica para distúrbios da pele | |
MY153062A (en) | Methods of treating gastrointestinal disorders independent of the intake of food | |
DE602005020309D1 (de) | Dehnungsstreifenbehandlung mit botulinumtoxin | |
AR065033A1 (es) | Metodos para prevenir y tratar trastornos neurodegenerativos | |
DE602006006068D1 (de) | Verwendung von botulintoxin zur verbesserung der magenentleerung und/oder behandlung von gerd | |
WO2009009393A3 (en) | Chromium complexes for improvement of memory and cognitive function | |
WO2009130600A8 (en) | Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy | |
DE602007002625D1 (de) | Verwendung von botulintoxin zur linderung von hodenschmerzen | |
HRP20100208T8 (en) | Method of treating acute rhinosinusitis | |
BRPI0509478A (pt) | tratamento de ferida por pressão | |
WO2010048264A3 (en) | Methods and compositions for the treatment of immunoinflammatory disorders | |
WO2008016665A3 (en) | Imidazoacridine compounds for treating flt3 -mediated disorders | |
WO2006078588A3 (en) | Improved methods for treating headache | |
SI1948216T1 (sl) | Zdravljenje akutne ledviäśne odpovedi s topnim trombomodulinom | |
WO2007105218A3 (en) | Composition and method for brain tumor therapy | |
UA40576U (ru) | Способ лечения интрагландулярного лимфаденита околоушной слюнной железы | |
RU2007136464A (ru) | Способ лечения себореи волосистой части головы | |
RU2004105675A (ru) | Способ комплексного лечения язв роговицы | |
RU2004106376A (ru) | Способ лечения хориоретинитов | |
WO2007134813A3 (en) | Use of desmodus salivary plasminogen activator (dspa) for treating venous thromboembolism | |
UA3548U (uk) | Спосіб лікування рухових конверсійних розладів |